Grifols, ES0171996087

Grifols stock heads into the open after adding 0.43 percent

Published on 09/25/2026 at 02:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 24, 2026, Grifols stock added 0.43 percent while the IBEX 35 fell 0.30 percent to 19,573.4 points. Health Canada license news remained a company-specific focus.

Fotorealistische Plasma-Fraktionierungsanlage, Biotech-Produktion, unbeschriftete Industriehalle
Fotorealistische Ansicht einer Plasma-Fraktionierungsanlage zeigt Grifols S.A. ES0171996087 in moderner Biotech-Produktion mit Reinraumtechnik, Illustration mit AI erstellt.

Grifols stock closed higher on the Madrid exchange on September 24, 2026, adding 0.43 percent. The shares outperformed the IBEX 35, which fell 0.30 percent to 19,573.4 points on the same session.

September 24, 2026 in numbers

Grifols, S.A. (ISIN ES0171996087) ended the session with a 0.43 percent gain on the Madrid exchange. The IBEX 35 declined 0.30 percent to 19,573.4 points, leaving Grifols 0.73 percentage points ahead of its reference index.

The session followed reports about Health Canada suspending the license to collect plasma at the company facility on Taylor Avenue in Winnipeg. As Reuters reported on September 24, 2026, Grifols said the decision had no impact on ongoing operations.

September 25, 2026 events

Spain's detailed second-quarter gross domestic product data are scheduled for 09:00 on September 25, 2026. The euro area money supply report follows at 10:00, while US durable goods orders are scheduled for 14:30 and the University of Michigan sentiment report for 16:00. The calendar was published by Aktiencheck on September 24, 2026.

Disclaimer...

en | ES0171996087 | GRIFOLS | boerse | 70179887 | bgmi